Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 102.50% is 45% above its 5-year average of 70.47%, near the high end of its 5-year range (52.79%–102.50%).
As of the fiscal period ended Tuesday, June 30, 2026. 40.57% above its 12-month average of 72.91%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
102.50%
GROSS MARGIN AVG TTM
72.91%
GROSS MARGIN AVG 3Y
70.40%
GROSS MARGIN AVG 5Y
69.71%
GROSS MARGIN AVG 10Y
69.34%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+40.57%
CURRENT VS 3Y AVG
+45.59%
CURRENT VS 5Y AVG
+47.03%
CURRENT VS 10Y AVG
+47.81%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.69%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+74.64%
vs the sector median at left
Teladoc Health, Inc.
Market Cap
$1.30B
Gross Margin
102.50%
TTM Avg
72.91%
3Y Avg
70.40%
5Y Avg
69.71%
Market Cap
$427.00M
Gross Margin
77.34%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
Market Cap
$2.43B
Gross Margin
49.52%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$15.31M
Gross Margin
53.33%
TTM Avg
48.95%
3Y Avg
47.93%
5Y Avg
47.45%
Market Cap
$2.90B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$7.05B
Gross Margin
67.64%
TTM Avg
76.65%
3Y Avg
78.21%
5Y Avg
76.94%
Market Cap
$7.23B
Gross Margin
14.38%
TTM Avg
17.24%
3Y Avg
38.82%
5Y Avg
59.22%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.30B | 102.50% | 72.91% | 70.40% | 69.71% |
| NRC Health (NRC)vs › | $458.40M | 56.33% | 58.27% | 60.30% | 61.48% |
| Shoulder Innovations, Inc. (SI)vs › | $427.00M | 77.34% | 76.74% | 77.57% | 77.57% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.43B | 49.52% | 50.81% | 52.12% | 52.25% |
| 23andMe Holding Co. (ME)vs › | $15.31M | 53.33% | 48.95% | 47.93% | 47.45% |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 58.69% | 59.64% | 63.22% | 64.62% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.05B | 67.64% | 76.65% | 78.21% | 76.94% |
| Oscar Health, Inc. (OSCR)vs › | $7.23B | 14.38% | 17.24% | 38.82% | 59.22% |
| Tempus AI, Inc. (TEM)vs › | $9.12B | 63.98% | 58.85% | 53.03% | 43.30% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.49B | 51.90% | 52.87% | 53.77% | 54.60% |
Gross Margin
102.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 102.50% |
| 2026-03-31 | 52.79% |
| 2025-12-31 | 69.32% |
| 2025-09-30 | 70.12% |
| 2025-06-30 | 69.85% |
| 2025-03-31 | 68.73% |
| 2024-12-31 | 70.50% |
| 2024-09-30 | 71.94% |
| 2024-06-30 | 70.73% |
| 2024-03-31 | 69.89% |
| 2023-12-31 | 70.72% |
| 2023-09-30 | 71.83% |
| 2023-06-30 | 70.79% |
| 2023-03-31 | 69.79% |
| 2022-12-31 | 70.38% |
| 2022-09-30 | 69.64% |
| 2022-06-30 | 69.20% |
| 2022-03-31 | 66.92% |
| 2021-12-31 | 68.43% |
| 2021-09-30 | 67.60% |
| 2021-06-30 | 68.15% |
| 2021-03-31 | 67.83% |
| 2020-12-31 | 67.93% |
| 2020-09-30 | 63.74% |
| 2020-06-30 | 62.34% |
| 2020-03-31 | 59.97% |
| 2019-12-31 | 64.63% |
| 2019-09-30 | 68.98% |
| 2019-06-30 | 68.04% |
| 2019-03-31 | 65.25% |
| 2018-12-31 | 67.39% |
| 2018-09-30 | 69.21% |
| 2018-06-30 | 70.72% |
| 2018-03-31 | 70.04% |
| 2017-12-31 | 70.55% |
| 2017-09-30 | 75.61% |
| 2017-06-30 | 77.52% |
| 2017-03-31 | 71.70% |
| 2016-12-31 | 73.20% |
| 2016-09-30 | 78.04% |
| 2016-06-30 | 73.98% |
| 2016-03-31 | 70.46% |
| 2015-12-31 | 71.39% |
| 2015-09-30 | 77.53% |
| 2015-06-30 | 73.78% |
| 2015-03-31 | 67.97% |
| 2014-12-31 | 70.84% |
| 2014-09-30 | 80.28% |
| 2014-06-30 | 80.30% |
| 2014-03-31 | 78.93% |
